Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Shares Outstanding (Diluted Average): 2009-2024

Historic Shares Outstanding (Diluted Average) for Cytokinetics (CYTK) over the last 8 years, with Dec 2024 value amounting to $111,979.

  • Cytokinetics' Shares Outstanding (Diluted Average) rose 1.95% to $119,982 in Q3 2025 from the same period last year, while for Sep 2025 it was $119,982, marking a year-over-year increase of 1.95%. This contributed to the annual value of $111,979 for FY2024, which is 16.01% up from last year.
  • According to the latest figures from FY2024, Cytokinetics' Shares Outstanding (Diluted Average) is $111,979, which was up 16.01% from $96,524 recorded in FY2023.
  • In the past 5 years, Cytokinetics' Shares Outstanding (Diluted Average) ranged from a high of $111,979 in FY2024 and a low of $64,524 during FY2020.
  • In the last 3 years, Cytokinetics' Shares Outstanding (Diluted Average) had a median value of $96,524 in 2023 and averaged $99,443.
  • Data for Cytokinetics' Shares Outstanding (Diluted Average) shows a peak YoY climbed of 19.16% (in 2021) over the last 5 years.
  • Cytokinetics' Shares Outstanding (Diluted Average) (Yearly) stood at $64,524 in 2020, then climbed by 19.16% to $76,886 in 2021, then grew by 16.83% to $89,825 in 2022, then rose by 7.46% to $96,524 in 2023, then increased by 16.01% to $111,979 in 2024.